CLINICAL_TRIALS
trial_result
· 2021-01-08
Clinical Trial Update: Histrelin Subcutaneous Implant in Children With Central Precocious Puberty [Phase 3]
Summary
Phase 3 trial update for a histrelin subcutaneous implant in children with central precocious puberty, results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Endo Pharmaceuticals | Conditions: Central Precocious Puberty | Phase 3 | Status: COMPLETED | Results posted: 2021-01-08